BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27064430)

  • 1. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.
    Abbott D; Johnson NE; Cannon-Albright LA
    Muscle Nerve; 2016 Oct; 54(4):783-5. PubMed ID: 27064430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cancer risks in myotonic dystrophy.
    Win AK; Perattur PG; Pulido JS; Pulido CM; Lindor NM
    Mayo Clin Proc; 2012 Feb; 87(2):130-5. PubMed ID: 22237010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.
    Emparanza JI; López de Munain A; Greene MH; Matheu A; Fernández-Torrón R; Gadalla SM
    Muscle Nerve; 2018 Oct; 58(4):517-522. PubMed ID: 30028904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer in relatives of patients with myotonic dystrophy: a population-based cohort study.
    Lund M; Diaz LJ; Gørtz S; Feenstra B; Duno M; Juncker I; Eiberg H; Vissing J; Wohlfahrt J; Melbye M
    Eur J Neurol; 2014 Sep; 21(9):1192-7. PubMed ID: 24838088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative risks for comorbidities associated with myotonic dystrophy: A population-based analysis.
    Johnson NE; Abbott D; Cannon-Albright LA
    Muscle Nerve; 2015 Oct; 52(4):659-61. PubMed ID: 26172955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-prevalence of other tumors in patients harboring pituitary tumors.
    Couldwell WT; Cannon-Albright LA
    J Neurosurg; 2014 Dec; 121(6):1474-7. PubMed ID: 25259568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign and malignant tumors in the UK myotonic dystrophy patient registry.
    Alsaggaf R; Wang Y; Marini-Bettolo C; Wood L; Nikolenko N; Lochmüller H; Greene MH; Gadalla SM
    Muscle Nerve; 2018 Feb; 57(2):316-320. PubMed ID: 28662292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
    Slattery ML; Kerber RA
    JAMA; 1993 Oct; 270(13):1563-8. PubMed ID: 8371466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tumors in patients with myotonic dystrophy: a population-based study.
    Gadalla SM; Pfeiffer RM; Kristinsson SY; Björkholm M; Landgren O; Greene MH
    Eur J Neurol; 2016 Mar; 23(3):542-7. PubMed ID: 26508558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retinal involvement in type 1 myotonic dystrophy: Literature review and presentation of a project based on the DM-Scope].
    Brignol TN; Leveziel N; Dogan C; Moussu-Haudebourg H; Bassez G
    J Fr Ophtalmol; 2018 Nov; 41(9):e445-e446. PubMed ID: 30389178
    [No Abstract]   [Full Text] [Related]  

  • 12. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.
    Gadalla SM; Hilbert JE; Martens WB; Givens S; Moxley RT; Greene MH
    Eur J Neurol; 2017 May; 24(5):713-718. PubMed ID: 28317292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial clustering of endometrial cancer in a well-defined population.
    Seger HM; Soisson AP; Dodson MK; Rowe KG; Cannon-Albright LA
    Gynecol Oncol; 2011 Jul; 122(1):75-8. PubMed ID: 21514633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic epidemiology of myotonic dystrophy.
    Mostacciuolo ML; Barbujani G; Armani M; Danieli GA; Angelini C
    Genet Epidemiol; 1987; 4(4):289-98. PubMed ID: 3666435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity and Cancer Disease Rates among Those at High-Risk for Alzheimer's Disease: A Population Database Analysis.
    Valentine D; Teerlink CC; Farnham JM; Rowe K; Kaddas H; Tschanz J; Kauwe JSK; Cannon-Albright LA
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
    Lund M; Diaz LJ; Ranthe MF; Petri H; Duno M; Juncker I; Eiberg H; Vissing J; Bundgaard H; Wohlfahrt J; Melbye M
    Eur Heart J; 2014 Aug; 35(32):2158-64. PubMed ID: 24742887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myotonic dystrophy experience: a North American cross-sectional study.
    Hagerman KA; Howe SJ; Heatwole CR;
    Muscle Nerve; 2019 Apr; 59(4):457-464. PubMed ID: 30677147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study of testicular cancer risk among children and young adults from Norway and Utah, USA.
    Kollerud RDR; Haugnes HS; Claussen B; Thoresen M; Nafstad P; Farnham JM; Blaasaas KG; Naess Ø; Cannon-Albright LA
    Int J Cancer; 2020 Sep; 147(6):1604-1611. PubMed ID: 32142164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasts in cancer prevalence in Connecticut, Iowa, and Utah.
    Micheli A; Yancik R; Krogh V; Verdecchia A; Sant M; Capocaccia R; Berrino F; Ries L
    Cancer; 2002 Jul; 95(2):430-9. PubMed ID: 12124844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.